Evaluation Methods in Biomedical Informatics (Health Informatics)
Description:
Heavily updated and revised from the successful first edition
Appeals to a wide range of informatics professionals, from students to on-site medical information system administrators
Includes case studies and real world system evaluations
References and self-tests for feedback and motivation after each chapter
Great for teaching purposes, the book is recommended for courses offered at universities such as Columbia University
Precise definition and use of terms
Best prices to buy, sell, or rent ISBN 9780387258898
Related Books
- 1
- 2
- Evaluation Methods in Biomedical Informatics (Health Informatics)Friedman, Charles P.Edition:Softcover reprint of hardcover 2nd ed. 2006ISBN-13:9781441920720
- Evaluation Methods in Medical Informatics (Computers and Medicine)Charles P. FriedmanISBN-13:9780387942285
- Evaluation Methods in Biomedical Informatics (Health Informatics)Friedman, Charles P.Edition:Softcover reprint of hardcover 2nd ed. 2006ISBN-13:9781441920720
- Evaluation Methods in Medical Informatics (Computers and Medicine)Charles P. FriedmanISBN-13:9780387942285
Frequently Asked Questions about Evaluation Methods in Biomedical Informatics (Health Informatics)
The price for the book starts from $5.98 on Amazon and is available from 21 sellers at the moment.
If you’re interested in selling back the Evaluation Methods in Biomedical Informatics (Health Informatics) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Evaluation Methods in Biomedical Informatics (Health Informatics) book, the best buyback offer comes from and is $ for the book in good condition.
The Evaluation Methods in Biomedical Informatics (Health Informatics) book is in very low demand now as the rank for the book is 4,760,301 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.